戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1  trachomatis was detected in 36 (30%) of 121 NGU case patients and in 4 (3%) of 117 control subjects
2 . genitalium was detected in 27 (22%) of 121 NGU case patients and in 5 (4%) of 117 control subjects
3                     We analyzed data from an NGU treatment trial among symptomatic heterosexual men a
4                    The incubation period for NGU caused by Mycoplasma genitalium is probably longer t
5    Clinical and microbiologic cure rates for NGU were somewhat low and there was no significant diffe
6 lasma genitalium is probably longer than for NGU caused by C. trachomatis.
7 prevalence was 14.7% (95% CI, 7.8%-21.6%) in NGU cases.
8 enitalium is a frequent undiagnosed cause of NGU in this population with rates of macrolide resistanc
9 s a role of this organism in the etiology of NGU.
10 d be modified to reduce treatment failure of NGU and the development of further resistance.
11 l resistance testing in men with symptoms of NGU as well as in their current sexual partner(s).
12 h were associated with signs and symptoms of NGU.
13 hese data have implications for treatment of NGU and control of trichomoniasis.
14      Persistent CT and MG after treatment of NGU are common, and were associated with clinical findin
15 r routine testing and empirical treatment of NGU should be modified to reduce treatment failure of NG
16  about single-dose azithromycin treatment of NGU, and emphasizing that NGU treatment should be guided
17 are diagnosis of N. gonorrhoeae infection or NGU in men, meatal swabs should be avoided in the absenc
18              Mycoplasma genitalium and other NGU pathogens were detected using nucleic acid amplifica
19  The clinical characteristics of symptomatic NGU have not been shown to identify the pathogen specifi
20 mycin treatment of NGU, and emphasizing that NGU treatment should be guided by etiologic diagnosis.
21 lium, which also commonly causes undiagnosed NGU, necessitates treatment with macrolides or fluoroqui
22 biotic therapy for nongonococcal urethritis (NGU) and cervicitis is aimed at Chlamydia trachomatis, b
23  a common cause of nongonococcal urethritis (NGU) and cervicitis.
24 thogens with acute nongonococcal urethritis (NGU) in heterosexual men presenting to an urban sexually
25 oeae infection and nongonococcal urethritis (NGU) in men.
26 he major causes of nongonococcal urethritis (NGU) worldwide but an uncommon sexually transmitted infe
27 s) associated with nongonococcal urethritis (NGU).
28 ly associated with nongonococcal urethritis (NGU).
29 onas is a cause of nongonococcal urethritis (NGU); however, studies of its prevalence in men have bee
30 is recommended for nongonococcal urethritis (NGU); recent evidence suggests their efficacy has declin
31 Washington, during the period 2007-2009 with NGU (defined as visible urethral discharge and/or >/=5 p
32       UU was only marginally associated with NGU in aggregate multivariable analyses, irrespective of
33        UP was not positively associated with NGU overall or among subgroups.
34       U. urealyticum was not associated with NGU.
35                Improved outcomes in men with NGU and better antimicrobial stewardship are likely to a
36 17 control subjects (P<.01), only 3 men with NGU were infected with both C. trachomatis and M. genita
37                                  In men with NGU, 19.9% were infected with trichomonas.
38 red azithromycin and doxycycline in men with NGU, hypothesizing that azithromycin was more effective
39 to assess the associations of UU and UP with NGU.
40 lyticum (UU) and Ureaplasma parvum (UP) with NGU using 2 separate control groups.
41     The absence of an association of UU with NGU among men with more lifetime sex partners suggests t
42 diseases clinic in Seattle, Washington, with NGU (visible urethral discharge or >/=5 polymorphonuclea
43  department (ED) attendees (n = 193) without NGU.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。